Case File Banner 24

Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents

Show Description +

Two newly approved anti-VEGF agents—faricimab (Vabysmo, Genentech/Roche) and aflibercept 8 mg (Eylea HD, Regeneron)—recently entered the clinic. Priya Sharma Vakharia, MD; Joseph M. Coney, MD; and Yasha S. Modi, MD, discuss how they might use these treatment options in practice, review how to switch patients from legacy treatments to newer therapies, and examine how the pivotal study data for these two agents affect their clinical decision-making.

Posted: 1/15/2024

Up Next

Real-World Treatment-Naïve Case: Bilateral Wet AMD in a 92-Year-Old Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD


Real-World Switch Case: Wet AMD Therapy in a Patient Averse to Injections

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Treatment-Naïve Case: Treating DME With a Dual-Inhibition Approach

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Step Therapy Case: A Challenging DME Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Roundtable: Balancing Safety Concerns With Unmet Needs in Wet AMD and DME Therapy

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Roundtable: Navigating the Treatment Landscape, and a Look at the Pipeline

Ferhina Ali, MD; Ash Abbey, MD; and Scott Walter, MD, MSc,

Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents

Two newly approved anti-VEGF agents—faricimab (Vabysmo, Genentech/Roche) and aflibercept 8 mg (Eylea HD, Regeneron)—recently entered the clinic. Priya Sharma Vakharia, MD; Joseph M. Coney, MD; and Yasha S. Modi, MD, discuss how they might use these treatment options in practice, review how to switch patients from legacy treatments to newer therapies, and examine how the pivotal study data for these two agents affect their clinical decision-making.

Posted: 1/15/2024


Please log in to leave a comment.